A prospective randomised double-blind parallel-group placebo-controlled study of gaboxadol in primary insomnia
Phase of Trial: Phase III
Latest Information Update: 28 Jul 2009
At a glance
- Drugs Gaboxadol - Ovid Therapeuticsgaboxadol (Primary)
- Indications Insomnia
- Focus Registrational; Therapeutic Use
- 28 Jul 2009 Actual end date (Nov 2005) added as reported by ClinicalTrials.gov.
- 19 May 2007 Results published as abstract and presented at APA in May 2007.
- 18 Nov 2005 New trial record.